Dashboard
Manage Tickers

ITRM Iterum Therapeutics plc

Nasdaq iterumtx.com


$ 0.38 $ -0.01 (-3.36 %)    

Thursday, 20-Nov-2025 13:41:53 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 590.89 $ -20.78 (-3.4 %)
DIA $ 459.26 $ -7.42 (-1.59 %)
SPY $ 656.50 $ -16.40 (-2.44 %)
TLT $ 89.20 $ 0.21 (0.24 %)
GLD $ 373.47 $ -1.71 (-0.46 %)
$ 0.385
$ 0.40
$ 0.38 x 200
$ 0.39 x 100
$ 0.36 - $ 0.41
$ 0.36 - $ 3.02
802,218
na
17.19M
$ 1.61
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 02-07-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-11-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-16-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 05-13-2022 03-31-2022 10-Q
16 03-28-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-13-2021 06-30-2021 10-Q
19 05-14-2021 03-31-2021 10-Q
20 03-12-2021 12-31-2020 10-K
21 11-16-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-12-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-14-2019 03-31-2019 10-Q
28 03-25-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
11/18/2025 17:06:49

iterum-therapeutics-q3-adj-eps-016-misses-011-estimate-sales-390000k
Iterum Therapeutics Q3 Adj. EPS $(0.16) Mi...
11/14/2025 12:01:22

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of...

earnings-scheduled-for-november-14-2025
Earnings Scheduled For November 14, 2025
11/14/2025 11:11:23

a-glimpse-of-iterum-therapeuticss-earnings-potential
A Glimpse of Iterum Therapeutics's Earning...
11/13/2025 15:04:11

top-stocks-with-earnings-this-week-plug-oklo-circle-and-more
Top Stocks With Earnings This Week: Plug, ...
11/10/2025 13:38:37

Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, P...

iterum-therapeutics-announces-us-commercial-launch-of-orlynvah-oral-tablets
Iterum Therapeutics Announces U.S. Commerc...
08/20/2025 12:02:42

Iterum Therapeutics plc (NASDAQ:ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infecti...

correction-iterum-therapeutics-q2-adj-eps-013-misses-011-estimate-cash-and-equivalents-of-13m-runway-into-2026
CORRECTION: Iterum Therapeutics Q2 Adj. EP...
08/05/2025 12:49:35

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

insights-ahead-iterum-therapeuticss-quarterly-earnings
Insights Ahead: Iterum Therapeutics's Quar...
08/04/2025 21:03:17

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/23/2025 21:05:58

iterum-shares-phase-3-trial-results-showing-how-its-oral-antibiotic-compares-to-augmentin-for-utis
Iterum Shares Phase 3 Trial Results Showin...
06/25/2025 11:06:17

Iterum Therapeutics plc (NASDAQ:ITRM) (the "Company" or "Iterum"), a company focused on delivering next generat...

iterum-therapeutics-partners-with-eversana-to-launch-orlynvah-in-us-by-q4-2025-targeting-hard-to-treat-utis
Iterum Therapeutics Partners With EVERSANA...
06/11/2025 11:15:48

Core News & Articles
Iterum Gets Pfizer to Extend $20M Mileston...
05/19/2025 11:12:52

Iterum Therapeutics plc (NASDAQ:ITRM) (the "Company" or "Iterum"), a company focused on delivering next generat...

iterum-therapeutics-q1-adj-eps-010-beats-014-estimate
Iterum Therapeutics Q1 Adj. EPS $(0.10) Be...
05/13/2025 11:01:18

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

a-look-ahead-iterum-therapeuticss-earnings-forecast
A Look Ahead: Iterum Therapeutics's Earnin...
05/12/2025 18:08:49

hc-wainwright--co-assumes-iterum-therapeutics-at-buy-announces-price-target-of-9
HC Wainwright & Co. Assumes Iterum Therape...
05/08/2025 11:04:19

HC Wainwright & Co. analyst Joseph Pantginis assumes Iterum Therapeutics (NASDAQ:ITRM) with a Buy rating and announces P...

iterum-therapeutics-announces-5m-registered-direct-offering-of-ordinary-shares-with-institutional-investor-5555556-ordinary-shares-at-purchase-price-of-090share
Iterum Therapeutics Announces $5M Register...
04/29/2025 12:21:12

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
04/29/2025 12:07:23

iterum-therapeutics-announces-that-one-poster-was-presented-on-impact-of-age-on-antibiotic-resistance-and-efficacy-of-antibiotics-for-women-with-uncomplicated-urinary-tract-infection-at-the-35th-annual-european-congress-of-clinical-microbiology-and-infectious-disease-in-vienna-austria-from-april-11-15-2025
Iterum Therapeutics Announces That One Pos...
04/14/2025 12:09:42

DUBLIN and CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM), a company focused on delivering n...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION